首頁 > 市場調查報告書 > 醫療設備

生技設備

一次性生物反應器市場規模、佔有率、成長分析（按產品類型、細胞類型、分子類型、應用、最終用途、使用類型和地區分類）—產業預測（2026-2033年）

市場調查報告書

商品編碼

1904474

一次性生物反應器市場規模、佔有率、成長分析（按產品類型、細胞類型、分子類型、應用、最終用途、使用類型和地區分類）—產業預測（2026-2033年）

Single Use Bioreactors Market Size, Share, and Growth Analysis, By Product, By Type Of Cell, By Molecule Type, By Application, By End-Use, By Usage Type, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，一次性生物反應器市場規模將達到 38.7 億美元，到 2025 年將成長至 45.3 億美元，到 2033 年將成長至 161.2 億美元，在預測期（2026-2033 年）內，複合年成長率為 17.19%。

一次性生物反應器（SUB）已成為細胞收集、培養、過濾、培養基製備和病毒去活化等環節不可或缺的工具，徹底改變了製藥和臨床領域。這些一次性系統採用伽馬射線滅菌的聚乙烯和聚合物材料製成，透過最大限度地減少批次間的設定時間，顯著簡化了生物生產流程。人們對高效細胞儲存和培養的日益關注正在推動市場成長。隨著對先進療法的需求不斷成長，緊湊型桌上型一次性生物反應器因其簡單性而備受青睞，減少了複雜的組裝和滅菌程序，並加快了周轉速度。此外，與傳統的不銹鋼生物反應器相比，一次性生物反應器通常具有更低的整體成本，從而在建造、運行和維護方面節省了大量成本，使其在生物製藥的開發和最佳化中發揮著不可估量的作用。

一次性生物反應器市場促進因素

生物製藥需求的成長主要源自於人口老化導致各種疾病的增加，老年人更容易出現健康問題。為了因應這項人口結構變化，全球企業正加大對生物製藥領域研發和生產流程的投入。此舉旨在推動產品創新，提升產能，以滿足不斷成長的市場需求。因此，包括一次性生物反應器在內的生物加工技術的進步，在有效應對這些挑戰方面發揮關鍵作用。

限制一次性生物反應器市場的因素

一次性生物反應器市場面臨的主要挑戰之一是缺乏可靠、精確且經濟高效的感測器，以滿足一次性生物反應器（SUB）的特定需求。為了在確保物料無菌的同時維持系統效率，整合到SUB中的感測器必須與現有平台完全相容。以往，在SUB系統中安裝感測器往往會影響產品質量，凸顯了開發先進感測器技術的必要性，這些技術既能滿足SUB的運作需求，又不影響輸出完整性。這項限制阻礙了SUB在各種應用中的整體有效性和廣泛應用。

一次性生物反應器市場趨勢

一次性生物反應器（SUB）市場在生物加工領域正經歷顯著成長，這主要得益於市場對靈活且擴充性的生產解決方案日益成長的需求。 SUB的諸多優勢，例如降低時間成本、提高營運效率以及減少交叉污染風險，是推動這一趨勢的關鍵因素。此外，隨著生物製藥公司尋求在降低營運成本的同時提高生產效率，SUB的吸引力也日益增強。這一市場的持續擴張反映了生物加工技術向創新技術的廣泛轉變，這些技術能夠滿足現代生產環境的需求，並將SUB定位為生物技術未來發展的關鍵組成部分。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Danaher（USA）
Sartorius AG（Germany）
Thermo Fisher Scientific（USA）
Merck KGaA（Germany）
Pall Corporation（USA）
Eppendorf SE（Germany）
ABEC（USA）
Celltainer（Netherlands）
Distek, Inc.（USA）
OmniBRx Biotechnologies（India）
PBS Biotech, Inc.（USA）
GE Healthcare（USA）
Cellexus Ltd.（UK）
Pierre Guerin（France）
CerCell ApS（Denmark）
Bioengineering AG（Switzerland）
Meissner Filtration Products（USA）
Kuhner Shaker（Switzerland）
Thermo Fisher Scientific（USA）

結論與建議

簡介目錄

Product Code: SQMIG35H2227

Single Use Bioreactors Market size was valued at USD 3.87 Billion in 2024 and is poised to grow from USD 4.53 Billion in 2025 to USD 16.12 Billion by 2033, growing at a CAGR of 17.19% during the forecast period (2026-2033).

Single-use bioreactors (SUBs) have transformed the pharmaceutical and clinical sectors, serving as essential tools for cell harvesting, culturing, filtration, media preparation, and virus inactivation. Constructed from gamma-sterilized polyethylene and polymer materials, these disposable systems significantly streamline the bioproduction process by minimizing preparation time between batches. The growing emphasis on efficient cell storage and cultivation is propelling market growth. As the demand for advanced therapeutics rises, smaller bench-top SUBs are favored for their simplicity, reducing the need for complex assembly and sterilization procedures, thus enhancing turnaround times. Additionally, SUBs often entail lower overall costs compared to traditional stainless-steel bioreactors, facilitating their widespread adoption by offering substantial savings in construction, operation, and maintenance, making them invaluable in biopharmaceutical development and optimization.

Top-down and bottom-up approaches were used to estimate and validate the size of the Single Use Bioreactors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Single Use Bioreactors Market Segments Analysis

Global Single Use Bioreactors Market is segmented by product, type of cell, molecule type, application, end-use, usage type and region. Based on product, the market is segmented into single-use bioreactor systems, single-use media bags, single-use assemblies and other related products. Based on type of cell, the market is segmented into mammalian cells, bacterial cells, yeast cells and other cells. Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy and other molecules. Based on application, the market is segmented into research and development, process development and bioproduction. Based on end-use, the market is segmented into pharmaceutical and biopharmaceutical companies, academic and research institutes, contract research organizations (CROs) and contract manufacturing organizations (CMOs). Based on usage type, the market is segmented into lab-scale production, pilot-scale production and large-scale production. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Single Use Bioreactors Market

The escalating demand for biopharmaceuticals is largely driven by the increasing prevalence of various diseases among the aging population, who are more vulnerable to health issues. In response to this shifting demographic landscape, companies worldwide are intensifying their focus on research and development, as well as manufacturing processes within the biopharmaceutical sector. This heightened emphasis aims to facilitate product innovation and enhance production capabilities to meet the growing needs of the market. As a result, the evolution of bioprocessing technologies, including single-use bioreactors, plays a crucial role in addressing these challenges effectively.

Restraints in the Single Use Bioreactors Market

A significant challenge facing the Single Use Bioreactors market is the absence of reliable, precise, and cost-effective sensors that cater to the specific requirements of Single Use Bioreactors (SUBs). Maintaining system efficiency while ensuring the sterility of materials necessitates that the sensors integrated into SUBs are fully compatible with existing platforms. Historically, the installation of sensors within SUB systems has led to diminished product quality, highlighting the critical need for advanced sensor technology that aligns with the operational demands of SUBs without compromising output integrity. This limitation hampers the overall effectiveness and adoption of SUBs in various applications.

Market Trends of the Single Use Bioreactors Market

The Single Use Bioreactors (SUBs) market is experiencing a significant surge in adoption within the bioprocessing sector, driven by the increasing need for flexible and scalable production solutions. This trend is fueled by the advantages that SUBs offer, including reduced time costs, streamlined operations, and diminished risk of cross-contamination. Additionally, as biopharmaceutical companies seek to enhance productivity and efficiency while minimizing overhead costs, the appeal of SUBs continues to grow. This ongoing market expansion reflects a broader shift towards innovative bioprocessing technologies that meet the demands of modern manufacturing environments, positioning SUBs as a vital component in the future of biotechnology.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies

Global Single Use Bioreactors Market Size by Product & CAGR (2026-2033)

Market Overview
Single-Use Bioreactor Systems
- Stirred Tank
- Wave-Mixed
- Bubble Column
Single-Use Media Bags
Single-Use Assemblies
Other Related Products

Global Single Use Bioreactors Market Size by Type Of Cell & CAGR (2026-2033)

Market Overview
Mammalian Cells
Bacterial Cells
Yeast Cells
Other Cells

Global Single Use Bioreactors Market Size by Molecule Type & CAGR (2026-2033)

Market Overview
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Stem Cells
Gene Therapy
Other Molecules

Global Single Use Bioreactors Market Size by Application & CAGR (2026-2033)

Market Overview
Research And Development
Process Development
Bioproduction

Global Single Use Bioreactors Market Size by End-Use & CAGR (2026-2033)

Market Overview
Pharmaceutical And Biopharmaceutical Companies
Academic And Research Institutes
Contract Research Organizations (CROs)
Contract Manufacturing Organizations (CMOs)

Global Single Use Bioreactors Market Size by Usage Type & CAGR (2026-2033)

Market Overview
Lab-Scale Production
Pilot-Scale Production
Large-Scale Production

Global Single Use Bioreactors Market Size & CAGR (2026-2033)

North America (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- USA
- Canada
Europe (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Danaher (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ABEC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celltainer (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Distek, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OmniBRx Biotechnologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PBS Biotech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellexus Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pierre Guerin (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CerCell ApS (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioengineering AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meissner Filtration Products (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuhner Shaker (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments